Clinical Trials Directory

Trials / Completed

CompletedNCT07502404

Lactobacillus Gasseri and Hormonal Regulation in Obese Women

Impact of Lactobacillus Gasseri on Weight Management and Endocrine Function in Overweight Women: A Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
110 (actual)
Sponsor
Wecare Probiotics Co., Ltd. · Industry
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

To evaluate the regulatory effect of Lactobacillus gasseri LG08 formula on visceral fat metabolism and sex hormone balance in obese women.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticThe trial period of this study is 12 weeks, and each patient will undergo 4 visits (in week 0, week 4, week 8, and week 12).
DIETARY_SUPPLEMENTMaltodextrinThe trial period of this study is 12 weeks, and each patient will undergo 4 visits (in week 0, week 4, week 8, and week 12).

Timeline

Start date
2025-04-28
Primary completion
2025-07-21
Completion
2025-10-25
First posted
2026-03-31
Last updated
2026-03-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07502404. Inclusion in this directory is not an endorsement.

Lactobacillus Gasseri and Hormonal Regulation in Obese Women (NCT07502404) · Clinical Trials Directory